Seizures: Classification
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Myocarditis II: Clinical Features and Diagnostic Tests
COPD: Pathogenesis and Clinical Features
Acute Respiratory Failure-II
Narcolepsy
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Oct 8, 2025

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
Published on: August 21, 2017
Jodi L Nelson1, Gregory M Blume, Saurabh K Bansal
1Department of Neurology (JN, GB, FW, XZ, and JK), University of Illinois College of Medicine Peoria, Illinois Neurologic Institute, OSF St. Francis Medical Center, Peoria, Illinois; Department of Neurology (JK and FW), Illinois Neurologic Institute OSF St. Francis Medical Center, Peoria, Illinois; and Department of Internal Medicine (SB), University of Illinois College of Medicine Peoria, OSF St. Francis Medical Center, Peoria, Illinois.
Opsoclonus-myoclonus-ataxia syndrome (OMAS) can be a post-SARS-CoV-2 complication. This case highlights OMAS with elevated neuron-specific enolase, successfully treated with rituximab.
Area of Science:
Background:
Observation:
Findings:
Implications: